APA (7th ed.) Citation

Fang, C., Chen, Y., Wu, N., Yin, J., Li, X., Huang, H., . . . Liu, Z. (2021). Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway. Nature Portfolio.

Chicago Style (17th ed.) Citation

Fang, Chao, Yi-Xin Chen, Na-Yiyuan Wu, Ji-Ye Yin, Xiang-Ping Li, Hsuan-Shun Huang, Wei Zhang, Hong-Hao Zhou, and Zhao-Qian Liu. Author Correction: MiR-488 Inhibits Proliferation and Cisplatin Sensibility in Non-small-cell Lung Cancer (NSCLC) Cells by Activating the EIF3a-mediated NER Signaling Pathway. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Fang, Chao, et al. Author Correction: MiR-488 Inhibits Proliferation and Cisplatin Sensibility in Non-small-cell Lung Cancer (NSCLC) Cells by Activating the EIF3a-mediated NER Signaling Pathway. Nature Portfolio, 2021.